Skip to main content

Table 1 The character of included literatures

From: Association of LIPC -250G/A and -514C/T polymorphisms and hypertension: a systematic review and meta-analysis

Author

Public Year

Location

Detection method

SNP

NOS

Group

N

Age

Gender (Male/Female)

SNP

HWE

CC(GG)

CT(GA)

TT(AA)

Χ2a

P

Bernard N

2007

Canada

PCR-ASO

rs1800588

6

HDCP

106

27 ± 4

0/106

63

40

3

2.776

0.0957

Control

169

27 ± 4

0/169

56

37

13

Lin H

2014

China

PCR-RFLP

rs1800588

6

HDCP

321

29.1 ± 5.6

0/321

127

151

43

0.267

0.6055

Control

331

27.9 ± 4.2

0/331

126

160

45

rs2070895

HDCP

321

29.1 ± 5.6

0/321

120

151

50

0.081

0.7754

Control

331

27.9 ± 4.2

0/331

119

161

51

Ríosgonzález BE

2014

Mexico

PCR-RFLP,PCR-AIRS

rs1800588

5

Case

160

47 ± 10

121/39

38

67

49

0.002

0.9691

Control

160

47 ± 11

114/46

35

78

44

Yin RX1

2012

China

PCR-RFLP

rs2070895

7

Case

330

49.9 ± 16.2

330/0

124

168

38

1.058

0.3036

Control

338

48.8 ± 11.8

338/0

158

152

28

Yin RX2

2012

rs2070895

Case

340

48.3 ± 15.8

0/340

143

131

66

4.716

0.0299

Control

344

47.1 ± 11.2

0/344

162

160

22

  1. SNP Single Nucleotide Polymorphism, a: likelihood-ratio Χ2; NOS Newcastle-Ottawa Scale, N The total number of including, SNP Single nucleotide polymorphisms, HWE Hardy-Weinberg equilibrium tests of control, HDCP Hypertensive disorders complicating pregnancy, 1:Male; 2: Female; PCR-ASO Polymerase chain reaction-allele-specific oligonucleotide, PCR-RFLP Polymerase chain reaction-restriction fragment length polymorphism, PCR-AIRS Polymerase chain reaction-artificial introduction of restriction sites